These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1398500)

  • 1. Effect of loxiglumide and atropine on erythromycin-induced reduction in gallbladder volume in human subjects.
    Jebbink MC; Masclee AA; van der Kleij FG; Schipper J; Rovati LC; Jansen JB; Lamers CB
    Hepatology; 1992 Oct; 16(4):937-42. PubMed ID: 1398500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying.
    Gielkens HA; de Boer SY; Lam WF; Rovati LC; Lamers CB; Masclee AA
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1227-31. PubMed ID: 9471030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A; Kulesza E; Konturek SJ
    Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal phase of human antro-pyloro-duodenal motility: cholinergic and CCK-mediated regulation.
    Katschinski M; Schirra J; Begliner C; Langbein S; Wank U; D'Amato M; Arnold R
    Eur J Clin Invest; 1996 Jul; 26(7):574-83. PubMed ID: 8864420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of somatostatin and loxiglumide on gallbladder motility.
    Lieverse RJ; Jansen JB; Jebbink MC; Masclee AA; Rovati LC; Lamers CB
    Eur J Clin Pharmacol; 1995; 47(6):489-92. PubMed ID: 7768249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythromycin stimulates gallbladder emptying and motilin release by atropine-sensitive pathways.
    Fiorucci S; Bosso R; Morelli A
    Dig Dis Sci; 1992 Nov; 37(11):1678-84. PubMed ID: 1358562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
    Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.
    Corazziari E; Ricci R; Biliotti D; Bontempo I; De Medici A; Pallotta N; Torsoli A
    Dig Dis Sci; 1990 Jan; 35(1):50-4. PubMed ID: 2295294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man.
    Beglinger C; Hildebrand P; Adler G; Werth B; Luo H; Delco F; Gyr K
    Eur J Clin Invest; 1992 Dec; 22(12):827-34. PubMed ID: 1282465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.
    Adler G; Reinshagen M; Koop I; Göke B; Schafmayer A; Rovati LC; Arnold R
    Gastroenterology; 1989 Apr; 96(4):1158-64. PubMed ID: 2647576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans.
    Malesci A; De Fazio C; Festorazzi S; Bonato C; Valentini A; Tacconi M; Rovati L; Setnikar I
    Gastroenterology; 1990 May; 98(5 Pt 1):1307-10. PubMed ID: 2323521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atropine, proglumide, and somatostatin analogue (SMS 201-995) on bombesin-induced gallbladder contraction and CCK secretion in humans.
    Mitsukawa T; Takemura J; Nishizono F; Nakatsuru K; Ohgo S; Matsukura S
    Am J Gastroenterol; 1989 Nov; 84(11):1371-4. PubMed ID: 2683738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of loxiglumide on gallbladder emptying in healthy volunteers.
    Niederau C; Heintges T; Rovati L; Strohmeyer G
    Gastroenterology; 1989 Nov; 97(5):1331-6. PubMed ID: 2792664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist.
    Baum F; Nauck MA; Ebert R; Cantor P; Hoffmann G; Choudhury AR; Schmidt WE; Creutzfeldt W
    Digestion; 1992; 53(3-4):189-99. PubMed ID: 1291406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
    Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A
    Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
    Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
    J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of erythromycin on gallbladder emptying in diabetic patients with and without autonomic neuropathy and high levels of motilin.
    Fiorucci S; Scionti L; Bosso R; Desando A; Bottini P; Marino C; Morelli A
    Dig Dis Sci; 1992 Nov; 37(11):1671-7. PubMed ID: 1425065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers.
    Niederau C; Schwarzendrube J; Lüthen R; Niederau M; Strohmeyer G; Rovati L
    Pancreas; 1992; 7(1):1-10. PubMed ID: 1557335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of duodenal juice on bombesin-stimulated cholecystokinin release during loxiglumide administration in man.
    Jebbink MC; Jansen JB; van der Kleij FG; Mooy DM; Rovati LC; Lamers CB
    Eur J Clin Invest; 1993 Sep; 23(9):529-33. PubMed ID: 8243522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.